ReviewHepatic medicine : evidence and research2017

Decreasing racial disparity with the combination of ledipasvir-sofosbuvir for the treatment of chronic hepatitis C.

Paul H Naylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.